Fortrea Holdings Inc. (FTRE)
NASDAQ: FTRE · Real-Time Price · USD
7.55
-0.48 (-5.98%)
Mar 31, 2025, 1:13 PM EDT - Market open

Company Description

Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide.

It offers clinical services that provides development and consulting services to clinical pharmacology and clinical development spectrum.

The company also offers delivery models that include full service, functional service provider, and hybrid service structures.

In addition, it delivers phase I – IV clinical trial management, clinical pharmacology, and consulting services.

Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.

Fortrea Holdings Inc.
Fortrea Holdings logo
Country United States
Founded 1996
Industry Biotechnology
Sector Healthcare
Employees 16,120
CEO Thomas Pike

Contact Details

Address:
8 Moore Drive
Durham, North Carolina 27709
United States
Phone 877 495 0816
Website fortrea.com

Stock Details

Ticker Symbol FTRE
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001965040
CUSIP Number 34965K107
ISIN Number US34965K1079
Employer ID 92-2796441
SIC Code 8071

Key Executives

Name Position
Thomas H. Pike Chief Executive Officer and Chairman
Jill McConnell Chief Financial Officer
Mark A. Morais Chief Operating Officer and President of Clinical Services
Drayton Virkler President and Chief Commercial Officer
Robert Parks Chief Accounting Officer
Dr. John J. Doyle M.D. Chief Scientific Officer and President of Consulting Services
Alejandro Martinez Galindo Chief Information Officer
Dave Cooper Chief Administrative Officer
Hima B. Inguva Head of Investor Relations and Corporate Development
J. Stillman Hanson J.D. General Counsel and Corporate Secretary

Latest SEC Filings

Date Type Title
Mar 14, 2025 144 Filing
Mar 14, 2025 144 Filing
Mar 14, 2025 144 Filing
Mar 13, 2025 144 Filing
Mar 13, 2025 144 Filing
Mar 12, 2025 144 Filing
Mar 12, 2025 144 Filing
Mar 10, 2025 8-K Current Report
Mar 3, 2025 10-K Annual Report
Mar 3, 2025 8-K Current Report